Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.

Saved in:
Bibliographic Details
Title: Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.
Authors: Angulo JC; Clinical Department, Universidad Europea de Madrid; Hospital Universitario de Getafe, Madrid, Spain. javier.angulo@universidadeuropea.es., Ciria Santos JP; Radiation Oncology Service, Hospital Universitario Donostia, Donostia, Spain., Gómez-Caamaño A; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Poza de Celis R; Department of Radiation Oncology, Hospital Universitario Araba, Gasteiz, Spain., González Sala JL; Urology Service, Corporació Sanitària Parc Taulí, Sabadell, Spain., García Garzón JM; Urology Service, Hospital General de Llerena, Llerena, Spain., Galán-Llopis JA; Urology Service, Hospital General Universitario de Alicante, Alicante, Spain., Pérez Sampietro M; Ipsen Pharma, S.A.U, Barcelona, Spain., Perrot V; Ipsen Pharma, S.A.U, Barcelona, Spain., Planas Morin J; Urology Service, Hospital Universitario Vall d'Hebrón, Barcelona, Spain.
Corporate Authors: ANARESISTANCE study group
Source: World journal of urology [World J Urol] 2022 Oct; Vol. 40 (10), pp. 2459-2466. Date of Electronic Publication: 2022 Sep 04.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-8726
DOI:10.1007/s00345-022-04108-x